36
Participants
Start Date
July 31, 2025
Primary Completion Date
June 30, 2027
Study Completion Date
July 31, 2027
Extended-release sodium oxybate
Participants will take Extended-release sodium Oxybate (Lumryz) 4.5-9 g oral suspension in approximately ⅓ cup of water orally once a day before bedtime. Dosage of Lumryz will be the same as the equivalent total dose of the Non-Extended-release Oxybate (Xywav or Xyrem) that participants use before starting the study
Non-extended-release oxybates
Participants will take Non-Extended-release Oxybates (Xyrem oral solution or Xywav oral solution) 4.5-9 g orally per night (divided into two doses, once before bedtime and another dose 2-4 hours later) at the same dose of Xyrem or Xywav that participants use before starting the study will be continued to compare with Extended-release sodium Oxybate (Lumryz)
RECRUITING
Stanford University, Redwood City
Collaborators (1)
Avadel
INDUSTRY
Stanford University
OTHER